| Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome G Barbara, V Stanghellini, R De Giorgio, C Cremon, GS Cottrell, D Santini, ... GASTROENTEROLOGY-BALTIMORE THEN PHILADELPHIA- 126 (3), 693-702, 2004 | 1783 | 2004 |
| Norovirus gastroenteritis C Cremon, R De Giorgio, G Barbara, RI Glass, UD Parashar, MK Estes New England Journal of Medicine 362 (6), 557-558, 2010 | 1423* | 2010 |
| Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. G Barbara, B Wang, V Stanghellini, R de Giorgio, C Cremon, G Di Nardo, ... Gastroenterology 132 (1), 26, 2007 | 929 | 2007 |
| Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators T Piche, G Barbara, P Aubert, SB Des Varannes, R Dainese, JL Nano, ... Gut 58 (2), 196-201, 2009 | 634 | 2009 |
| Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms C Cremon, L Gargano, AM Morselli-Labate, D Santini, RF Cogliandro, ... Official journal of the American College of Gastroenterology| ACG 104 (2 …, 2009 | 446 | 2009 |
| Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome S Buhner, Q Li, S Vignali, G Barbara, R De Giorgio, V Stanghellini, ... Gastroenterology 137 (4), 1425-1434, 2009 | 429 | 2009 |
| Interactions between commensal bacteria and gut sensorimotor function in health and disease G Barbara, V Stanghellini, G Brandi, C Cremon, G Di Nardo, R De Giorgio, ... Official journal of the American College of Gastroenterology| ACG 100 (11 …, 2005 | 427 | 2005 |
| A role for inflammation in irritable bowel syndrome? G Barbara, R De Giorgio, V Stanghellini, C Cremon, R Corinaldesi Gut 51 (suppl 1), i41-i44, 2002 | 395 | 2002 |
| New pathophysiological mechanisms in irritable bowel syndrome G Barbara, R De Giorgio, V Stanghellini, C Cremon, B Salvioli, ... Alimentary pharmacology & therapeutics 20 (s2), 1-9, 2004 | 320 | 2004 |
| Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome C Cremon, G Carini, B Wang, V Vasina, RF Cogliandro, R De Giorgio, ... Official journal of the American College of Gastroenterology| ACG 106 (7 …, 2011 | 276 | 2011 |
| The immune system in irritable bowel syndrome G Barbara, C Cremon, G Carini, L Bellacosa, L Zecchi, R De Giorgio, ... Journal of neurogastroenterology and motility 17 (4), 349, 2011 | 261 | 2011 |
| Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease G Barbara, E Scaioli, MR Barbaro, E Biagi, L Laghi, C Cremon, ... Gut 66 (7), 1252-1261, 2017 | 225 | 2017 |
| Inflammatory and microbiota-related regulation of the intestinal epithelial barrier G Barbara, MR Barbaro, D Fuschi, M Palombo, F Falangone, C Cremon, ... Frontiers in nutrition 8, 718356, 2021 | 198 | 2021 |
| Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof‐of‐concept study R Corinaldesi, V Stanghellini, C Cremon, L Gargano, RF Cogliandro, ... Alimentary pharmacology & therapeutics 30 (3), 245-252, 2009 | 192 | 2009 |
| Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome G Barbara, C Cremon, R De Giorgio, G Dothel, L Zecchi, L Bellacosa, ... Current gastroenterology reports 13 (4), 308-315, 2011 | 160 | 2011 |
| Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome G Dothel, MR Barbaro, H Boudin, V Vasina, C Cremon, L Gargano, ... Gastroenterology 148 (5), 1002-1011. e4, 2015 | 159 | 2015 |
| Colonic immune cells in irritable bowel syndrome: a systematic review and meta‐analysis M Bashashati, S Moossavi, C Cremon, MR Barbaro, S Moraveji, G Talmon, ... Neurogastroenterology & Motility 30 (1), e13192, 2018 | 155 | 2018 |
| Pre-and probiotic overview C Cremon, MR Barbaro, M Ventura, G Barbara Current opinion in pharmacology 43, 87-92, 2018 | 153 | 2018 |
| Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome G Barbara, L Zecchi, R Barbaro, C Cremon, L Bellacosa, M Marcellini, ... Journal of clinical gastroenterology 46, S52-S55, 2012 | 132 | 2012 |
| Randomised controlled trial of mesalazine in IBS G Barbara, C Cremon, V Annese, G Basilisco, F Bazzoli, M Bellini, ... Gut 65 (1), 82-90, 2016 | 129 | 2016 |
Fabrizio De PontiProfessor of Pharmacology, University of Bologna在 unibo.it 的电子邮件经过验证
